Next 10 |
- Project To Increase RNAP Manufacturing Capacity and Reduce Unit Costs of Goods - - Project Slated for Completion Coincident with Company's Planned Initiation of GMP Manufacturing for Linea ™ DNA IVT Templates - STONY BROOK, NY and JUPITER, FL / ACCESSWIRE / March 18, 2024 /...
STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea™ IVT and Linea™ DNA platforms at the 24 th Annual World Vaccine Congress, which will be held April 1 - 4, 2024. A...
2024-03-12 11:58:04 ET More on Applied DNA Sciences Applied DNA Sciences GAAP EPS of -$0.09 beats by $0.22, revenue of $0.89M beats by $0.11M Applied DNA announces $3.44M registered direct offering Read the full article on Seeking Alpha For further details se...
2024-02-09 13:32:06 ET Applied DNA Sciences, Inc. (APDN) Q1 2024 Results Conference Call February 08, 2024 04:30 PM ET Company Participants Sanjay Hurry - Head of IR Beth Jantzen - Chief Financial Officer Dr. James Hayward - Chairman, President and CEO Clay S...
2024-02-08 17:13:15 ET More on Applied DNA Sciences Applied DNA Sciences, Inc. (APDN) Q4 2023 Earnings Call Transcript Applied DNA announces $3.44M registered direct offering Seeking Alpha’s Quant Rating on Applied DNA Sciences Historical earnings data...
- Company On Track to Initiate First-Phase GMP Production Capacity for mRNA Critical Starting Materials During First Half of Calendar 2024, Projects Initial Facility Capacity to Enable up to $15 Million 1 of Linea IVT Revenue 2 Annually - - Conference Call/Webcast Scheduled for Today at 4:...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
STONY BROOK, NY / ACCESSWIRE / February 5, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its first quarter fiscal 2024 financial results after market close o...
STONY BROOK, NY / ACCESSWIRE / February 2, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has closed its previously announced registered direct offering of its common stock priced at-the-market under Nasdaq rules w...
2024-01-31 08:32:10 ET More on Applied DNA Sciences Applied DNA Sciences, Inc. (APDN) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Applied DNA Sciences Historical earnings data for Applied DNA Sciences Financial information for Appl...
News, Short Squeeze, Breakout and More Instantly...
Applied DNA Sciences Inc. Company Name:
APDN Stock Symbol:
NASDAQ Market:
Applied DNA Sciences Inc. Website:
- Project To Increase RNAP Manufacturing Capacity and Reduce Unit Costs of Goods - - Project Slated for Completion Coincident with Company's Planned Initiation of GMP Manufacturing for Linea ™ DNA IVT Templates - STONY BROOK, NY and JUPITER, FL / ACCESSWIRE / March 18, 2024 /...
STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea™ IVT and Linea™ DNA platforms at the 24 th Annual World Vaccine Congress, which will be held April 1 - 4, 2024. A...
- Company On Track to Initiate First-Phase GMP Production Capacity for mRNA Critical Starting Materials During First Half of Calendar 2024, Projects Initial Facility Capacity to Enable up to $15 Million 1 of Linea IVT Revenue 2 Annually - - Conference Call/Webcast Scheduled for Today at 4:...